NL
TEVA icon

NWAM LLC’s Teva Pharmaceuticals TEVA Stock Holding History

NWAM LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,411
Closed -$189K – 524
2021
Q1 		$189K Sell
16,411
-13,541
-45% -$155K 0.02% 462
2020
Q4 		$289K Buy
29,952
+1,400
+5% +$13.4K 0.03% 357
2020
Q3 		$257K Sell
28,552
-146
-0.5% -$1.54K 0.04% 203
2020
Q2 		$354K Buy
28,698
+1,254
+5% +$14.2K 0.05% 298
2020
Q1 		$246 Buy
27,444
+2,830
+11% +$29K 0.01% 328
2019
Q4 		$241K Buy
24,614
+1,700
+7% +$15.2K 0.04% 343
2019
Q3 		$158K Sell
22,914
-1,700
-7% -$13K 0.03% 370
2019
Q2 		$227K Sell
24,614
-2,015
-8% -$24.3K 0.05% 323
2019
Q1 		$418K Sell
26,629
-3,454
-11% -$60.9K 0.09% 213
2018
Q4 		$464K Buy
30,083
+915
+3% +$18.8K 0.12% 170
2018
Q3 		$628K Sell
29,168
-875
-3% -$20.3K 0.14% 154
2018
Q2 		$731K Sell
30,043
-475
-2% -$9.69K 0.17% 134
2018
Q1 		$522K Sell
30,518
-1,662
-5% -$32.5K 0.13% 171
2017
Q4 		$610K Buy
32,180
+8,484
+36% +$128K 0.15% 143
2017
Q3 		$417K Buy
23,696
+7,772
+49% +$175K 0.11% 187
2017
Q2 		$529K Sell
15,924
-156
-1% -$4.83K 0.09% 151
2017
Q1 		$516K Buy
16,080
+5,674
+55% +$194K 0.16% 146
2016
Q4 		$377K Buy
+10,406
New +$415K 0.13% 171
2014
Q4 		– Sell
-4,163
Closed -$224K – 286
2014
Q3 		$224K Sell
4,163
-28
-0.7% -$1.48K 0.08% 240
2014
Q2 		$220K Buy
+4,191
New +$214K 0.07% 260

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

NWAM LLC's TEVA Position: Q2 2021 in Review

NWAM LLC sold out of Teva Pharmaceuticals (TEVA) in Q2 2021, closing a stake of 16,411 shares — an estimated $189K sold.

NWAM LLC first reported a position in TEVA in Q2 2014 and held it in 20 quarters. The position peaked at $731K in Q2 2018. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • NWAM LLC reported no remaining Teva Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • NWAM LLC sold 16,411 Teva Pharmaceuticals shares in Q2 2021, an estimated $189K.
  • NWAM LLC first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 20 quarters.
  • NWAM LLC's Teva Pharmaceuticals position peaked at $731K in Q2 2018.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on NWAM LLC's 13F filing for Q2 2021, filed 4 Aug 2021.